Notes from the Field: An Outbreak of West Nile Virus — Arizona, 2019

Irene Ruberto, PhD1; Melissa Kretschmer, MA2; Karen Zabel, MSN2; Rebecca Sunenshine, MD2,3; Kirk Smith, PhD4; John Townsend4; Danielle Richard1; Laura M. Erhart, MPH1; Nicholas Staab, MD1; Ken Komatsu, MPH1; Heather Venkat, DVM1,3 (View author affiliations)

View suggested citation
Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

West Nile virus (WNV), a mosquitoborne flavivirus,* was first identified in the United States in 1999 and first reported in Arizona in 2003 (with 12 human cases); 391 human cases were reported in 2004. Since that time, a median of 103 cases (range = 21–391) have been reported in Arizona annually. During week 28 in 2019, the Arizona Department of Health Services (ADHS) recorded the highest weekly WNV case count (23) ever reported in Arizona (an incidence of 0.32 cases per 100,000 population) (Figure). This prompted ADHS to investigate the outbreak’s severity to inform prevention, resource allocation, and public messaging.

The 2019 total of 174 WNV cases reported in Arizona was the largest number in the state since 2004, and the second largest number of any state in the United States for that year (1). The 2019 incidence in Arizona (2.4 cases per 100,000 population; 65% confirmed) was 50% above the median annual incidence for 2005–2018 (1.6 cases per 100,000 population). Maricopa County, which includes the greater metropolitan Phoenix area, reported 3.7 cases per 100,000 population (the highest county rate since 2004). Cases were classified according to the national WNV surveillance case definition (2).

Arizona usually experiences a biphasic WNV season during the summer monsoon rains, with first peak cases occurring in early August and the second peak in late September (3). In 2019, the first peak occurred during week 28 (mid-July), 3 weeks earlier than the mean first peak during 2004–2018 (week 31, range = 26–46). The second peak in 2019 occurred during week 35 (end of August), 3 weeks earlier than the mean during 2004–2018 (week 38, range = 36–46). The number of cases during the first peak in 2019 was 72% above the 2004–2018 first peak average, whereas the number of cases during the second peak was 22% below the second peak average for these years.

In 2019, among 174 WNV cases reported across the state, 132 (76%) were identified as neuroinvasive diseases (130 were either meningitis or encephalitis), similar to recent state and national trends (1,4). Demographics of persons infected in 2019 did not differ significantly from those infected during previous years in Arizona; 58% of cases were in males and the median age was 64 years (range = 6–92 years). The case-fatality rate for all 174 cases was 10%, similar to historical statewide data (median = 7%, range = 0–22%). Statewide, 23 WNV viremic blood donors were reported in 2019, 52% higher than the historical median for available years (2006–2018) (1).

In Maricopa County, 0.60% (417 of 69,487) mosquito pools tested positive for WNV in 2019 compared with 0.18% (124 of 67,146) in 2018 and 0.34% (209 of 60,486) in 2017 (5). In addition, the vector index§ (WNV transmission activity in mosquito populations) (6) reached 19.4 in early June 2019, the highest ever detected in the county. This increase in vector index preceded the peak of human WNV cases in Maricopa County by approximately 6 weeks. Arizona experienced a particularly wet fall/winter 2018; an increase in vegetation during spring 2019 might have boosted the mosquito and bird populations and amplified WNV sooner than usual, leading to earlier and more human WNV infections (7).

ADHS and Maricopa County informed health care providers and the public about the outbreak and distributed educational materials and mosquito repellent across the state. CDC, ADHS, and Maricopa County further investigated WNV presence in the bird and mosquito populations around the Phoenix area.

Ongoing investigation by ADHS, CDC, local vector control agencies, and university partners into factors influencing mosquito abundance, WNV transmission (amplification and suppression), or other factors, such as modeling weather patterns with bird and mosquito population dynamics (7), insecticide resistance of mosquitoes, or WNV strain analysis in birds and mosquitoes might help inform future public health prevention and response activities regarding WNV outbreaks.

Acknowledgments

Arizona State Public Health Laboratory; Maricopa County Department of Public Health; Vector Control Division, Maricopa County Environmental Services Department; Arboviral Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.

Corresponding author: Heather Venkat, hvenkat@cdc.gov, 480-273-6162.


1Arizona Department of Health Services; 2Maricopa County Department of Public Health, Phoenix, Arizona; 3Career Epidemiology Field Officer Program, Center for Preparedness and Response, CDC; 4Vector Control Division, Maricopa County Environmental Services Department, Phoenix, Arizona.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.


* https://www.cdc.gov/vhf/virus-families/flaviviridae.html

https:/www.azdhs.gov/preparedness/epidemiology-disease-control/mosquito-borne/west-nile-virus/index.php#informationexternal icon

§ The vector index is calculated by determining the average number of infected mosquitoes collected per trap in an area, therefore it parallels the mosquito pool positivity.

https://www.weather.gov/psr/Year_in_Review_2018external icon

References

  1. Arizona Department of Health Services. Disease data, statistics & reports. Data & statistics past years. Phoenix, AZ: Arizona Department of Health Services, 2020. https:/www.azdhs.gov/preparedness/epidemiology-disease-control/index.php#data-stats-past-yearsexternal icon
  2. CDC. Arboviral diseases, neuroinvasive and non-neuroinvasive 2015 case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://wwwn.cdc.gov/nndss/conditions/arboviral-diseases-neuroinvasive-and-non-neuroinvasive/case-definition/2015
  3. Godsey MS Jr, Burkhalter K, Young G, et al. Entomologic investigations during an outbreak of West Nile virus disease in Maricopa County, Arizona, 2010. Am J Trop Med Hyg 2012;87:1125–31. CrossRefexternal icon PubMedexternal icon
  4. McDonald E, Martin SW, Landry K, et al. West Nile virus and other domestic nationally notifiable arboviral diseases—United States, 2018. MMWR Morb Mortal Wkly Rep 2019;68:673–8. CrossRefexternal icon PubMedexternal icon
  5. Arizona Department of Health Services. Mosquitoes of Arizona. Data and maps. Phoenix, AZ: Arizona Department of Health Services, 2020. https:/www.azdhs.gov/preparedness/epidemiology-disease-control/mosquito-borne/mosquitoes-of-az/index.php#data-and-mapsexternal icon
  6. Gujral IB, Zielinski-Gutierrez EC, LeBailly A, Nasci R. Behavioral risks for West Nile virus disease, northern Colorado, 2003. Emerg Infect Dis 2007;13:419–25. CrossRefexternal icon PubMedexternal icon
  7. Manore CA, Davis J, Christofferson RC, Wesson DM, Hyman JM, Mores CN. Towards an early warning system for forecasting human West Nile virus incidence. PLoS Curr 2014;6. CrossRefexternal icon
Return to your place in the textFIGURE. West Nile virus disease cases and incidence per 100,000 population — Arizona, 2004–2019
Figure is a line graph that depicts cases and incidence of West Nile virus in Arizona during 2004–2019.

Suggested citation for this article: Ruberto I, Kretschmer M, Zabel K, et al. Notes from the Field: An Outbreak of West Nile Virus — Arizona, 2019. MMWR Morb Mortal Wkly Rep 2021;70:123–124. DOI: http://dx.doi.org/10.15585/mmwr.mm7004a4external icon.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In:pdf icon PDF [109K]
Page last reviewed: January 28, 2021